Sandercock Brett bought RMD

July 1, 2025 · Form 4 insider transaction

Sandercock Brett bought 917 shares of ResMed Inc. at $101.64 per share, a transaction worth $93.2K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Acquired (buy-side)
Shares
917
Price
$101.64
Total value
$93.2K
Role
SecurityResMed Common Stock
Transaction codeM: Option exercise
Transaction dateJuly 1, 2025
Filing dateJuly 2, 2025
Shares owned after88,166
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

The transaction was conducted under a Rule 10b5-1 plan adopted February 19, 2025.

View the original Form 4 on SEC EDGAR